Antibody- and Fc-receptor-based therapeutics for malaria

Clinical Science

Volumn 110, Issue 1, 2006, Pages 11-19

  Shi, Jianguo ^a   McIntosh, Richard S ^a   Pleass, Richard J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Antibody; Fc receptor; Immunization; Immunoglobulin; Malaria; Plasmodium antigen

Indexed keywords

ANTIBODY; FC RECEPTOR; MALARIA VACCINE;

ANTIGEN BINDING; GENETIC ENGINEERING; GENETIC POLYMORPHISM; HUMAN; IMMUNOREGULATION; INNATE IMMUNITY; MALARIA; MALARIA CONTROL; NONHUMAN; PRIORITY JOURNAL; REVIEW; VACCINATION;

ANIMALS; ANTIBODIES, PROTOZOAN; HUMANS; IMMUNIZATION, PASSIVE; MALARIA; MALARIA VACCINES; PLASMODIUM; POLYMORPHISM, GENETIC; RECEPTORS, FC; RECOMBINANT FUSION PROTEINS;

EID: 30344485159     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20050136     Document Type: Review

References (80)

1. Snow, R. W., Guerra, C. A., Noor, A. M., Myint, H. Y. and Hay, S. I. (2005) The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature (London) 434, 214-217
2. Hudson, P. J. and Souriau, C. (2003) Engineered antibodies. Nat. Med. 9, 129-134
3. Nathan, C. (2002) Catalytic antibody bridges innate and adaptive immunity. Science 298, 2143-2144
4. MacLennan, I. and Vinuesa, C. (2002) Dendritic cells, BAFF, and APRIL: innate players in adaptive antibody responses. Immunity 17, 235-238
5. Gura, T. (2002) Therapeutic antibodies: magic bullets hit the target. Nature (London) 417, 584-586
6. Boes, M. (2000) Role of natural and immune IgM antibodies in immune responses. Mol. Immunol. 37, 1141-1149
7. Woof, J. M. and Burton, D. (2004) Human antibody-Fc receptor interactions illuminated by crystal structures. Nat. Rev. Immunol. 4, 89-99
8. Monteiro, R. C. and van de Winkel, J. G. (2003) IgA Fc receptors. Annu. Rev. Immunol. 21, 177-204
9. Gould, H. J., Sutton, B. J., Beavil, A. J. et al. (2003) The biology of IgE and the basis of allergic disease. Annu. Rev. Immunol. 21, 579-628
10. Preud'homme, J. L., Petit, I., Barra, A., Morel, F., Lecron, J. C. and Lelievre, E. (2000) Structural and functional properties of membrane and secreted IgD. Mol Immunol. 37, 871-887
11. Kraneveld, A. D., Kool, M., van Houwelingen, A. H. et al. (2005) Elicitation of allergic asthma by immunoglobulin free light chains. Proc. Natl. Acad. Sci U.S.A. 102, 1578-1583
12. Casadevall, A. and Pirofski, L. A. (2003) Antibody-mediated regulation of cellular immunity and the inflammatory response. Trends Immunol. 24, 474-478
13. Samuelsson, A., Towers, T. L. and Ravetch, J. V. (2001) Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 291, 484-486
14. Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J. and Marshak-Rothstein, A. (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature (London) 416, 603-607
15. Royle, L., Roos, A., Harvey, D. J. et al. (2003) Secretory IgA N- and O-glycans provide a link between the innate and adaptive immune systems. J. Biol. Chem. 278, 20140-20153
16. Cohen, S., McGregor, I. A. and Carrington, S. (1961) γ-Globulin and acquired immunity to human malaria. Nature (London) 192, 733-737
17. Bouharoun-Tayoun, H., Attanath, P., Sabchareon, A., Chongsuphajaisiddhi, T. and Druilhe, P. (1990) Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J. Exp. Med. 172, 1633-1641
18. Good, M. F., Kaslow, D. C. and Miller, L. H. (1998) Pathways and strategies for developing a malaria blood-stage vaccine. Annu. Rev. Immunol. 16, 57-87
19. Bouharoun-Tayoun, H., Oeuvray, C., Lunel, F. and Druilhe, P. (1995) Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J. Exp. Med. 182, 409-418
20. Anders, R. F., Coppel, R. F., Brown, G. V. and Kemp, D. J. (1988) Ags with repeated amino acid sequences from the asexual blood stages of Plasmodium falciparum. Prog. Allergy 41, 148-172
21. Quinn, T. C. and Wyler, D. J. (1979) Mechanisms of action of hyperimmune serum in mediating protective immunity to rodent malaria (Plasmodium berghei). J. Immunol. 123, 2245-2249
22. Pleass, R. J., Ogun, S. A., McGuinness, D. H., van de Winkel, J. G., Holder, A. A. and Woof, J. M. (2003) Novel antimalarial antibodies highlight the importance of the antibody Fc region in mediating protection. Blood 102, 4424-4430
23. Badell, E., Oeuvray, C., Moreno, A. et al. (2000) Human malaria in immunocompromised mice: an in vivo model to study defense mechanisms against Plasmodium falciparum. J. Exp. Med. 192, 1653-1660
24. Good, M. F. (2001) Towards a blood-stage vaccine for malaria: are we following all the leads? Nat. Rev. Immunol. 1, 117-125
25. Hulett, M. D. and Hogarth, P. M. (1994) Molecular basis of Fc receptor function. Adv. Immunol. 57, 1-127
26. Pleass, R. J. and Woof, J. M. (2001) Fc-receptors and immunity to parasites. Trends Parasitol. 17, 545-551
27. Takai, T., Li, M., Sylvestre, D., Clynes, R. and Ravetch, J. V. (1994) FcRγ chain deletion results in pleiotrophic effector cell defects. Cell 76, 519-529
28. Yoneto, T., Waki, S. and Takai, T. (2001) A critical role of Fc receptor-mediated antibody-dependent phagocytosis in the host resistance to blood-stage Plasmodium berghei XAT infection. J. Immunol. 166, 6236-6241
29. Rotman, H. L., Daly, T. M., Clynes, R. and Long, C. A. (1998) Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model. J. Immunol. 161, 1908-1912
30. Yuan, R., Clynes, R., Oh, J., Ravetch, J. V. and Scharff, M. D. (1998) Antibody-mediated modulation of Cryptococcus neoformans infection is dependent on distinct Fc receptor functions and IgG subclasses. J. Exp. Med. 187, 641-648
31. Gavin, A. L., Barnes, N., Dijstelbloem, H. M. and Hogarth, P. M. (1998) Identification of the mouse IgG3 receptor: implications for antibody effector function at the interface between innate and adaptive immunity. J. Immunol. 160, 20-23
32. Ioan-Facsinay, A., de Kimpe, S. J., Hellwig, S. M. et al. (2002) Fcγ RI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity 16, 391-402
33. Barnes, N., Gavin, A. L., Tan, P. S., Mottram, P., Koentgen, F. and Hogarth, P. M. (2002) Fcγ RI-deficient mice show multiple alterations to inflammatory and immune responses. Immunity 16, 379-389
34. van Vugt, M. J., Kleijmeer, M. J., Keler, T. et al. (1999) The Fcγ RIa (CD64) ligand binding chain triggers major histocompatibility complex class II Ag presentation independently of its associated FcRγ-chain. Blood 94, 808-817
35. Beekman, J. M., Bakema, J. E., van de Winkel, J. G. and Leusen, J. H. (2004) Direct interaction between Fcγ RI (CD64) and periplakin controls receptor endocytosis and ligand binding capacity. Proc. Natl. Acad. Sci. U.S.A. 101, 10392-10397
36. Vukovic, P., Hogarth, P. M., Barnes, N., Kaslow, D. C. and Good, M. F. (2000) Immunoglobulin G3 antibodies specific for the 19-kilodalton carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein 1 transfer protection to mice deficient in Fc-γ RI receptors. Infect. Immun. 68, 3019-3022
37. Shibuya, A., Sakamoto, N., Shimizu, Y. et al. (2000) Fcα/μ receptor mediates endocytosis of IgM-coated microbes. Nat. Immunol. 1, 441-446
38. Ferreira, M. U., Kimura, E. A., Katzin, A. M. et al. (1998) The IgG-subclass distribution of naturally acquired antibodies to Plasmodium falciparum, in relation to malaria exposure and severity. Ann. Trop. Med. Parasitol. 92, 245-256
39. Davis, R. S., Ehrhardt, G. R., Leu, C. M., Hirano, M. and Cooper, M. D. (2005) An extended family of Fc receptor relatives. Eur. J. Immunol. 35, 1-7
40. Hatzivassiliou, G., Miller, I., Takizawa, J. et al. (2001) IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity 14, 277-289
41. Shi, Y. P., Nahlen, B. L., Kariuki, S., Urdahl, K. B., McElroy, P. D., Roberts, J. M. and Lal, A. A. (2001) Fcγ receptor IIa (CD32) polymorphism is associated with protection of infants against high-density Plasmodium falciparum infection. VII. Asembo Bay Cohort Project. J. Infect. Dis. 184, 107-111
42. Cooke, G. S., Aucan, C., Walley, A. J. et al. (2003) Association of Fcγ receptor IIa (CD32) polymorphism with severe malaria in West Africa. Am. J. Trop. Med. Hyg. 69, 565-568
43. Omi, K., Ohashi, J., Patarapotikul, J. et al. (2002) Fcγ receptor IIA and IIIB polymorphisms are associated with susceptibility to cerebral malaria. Parasitol. Int. 51, 361-366
44. Brouwer, K. C., Lal, A. A., Mirel, L. B. et al. (2004) Polymorphism of Fc receptor IIa for immunoglobulin G is associated with placental malaria in HIV-1-positive women in western Kenya. J. Infect. Dis. 190, 1192-1198
45. Warmerdam, P. A., van de Winkel, J. G., Vlug, A., Westerdaal, N. A. and Capel, P. J. (1991) A single amino acid in the second Ig-like domain of the human Fc γ receptor II is critical for human IgG2 binding. J. Immunol. 147, 1338-1343
46. Bouharoun-Tayoun, H. and Druilhe, P. (1992) Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect. Immun. 60, 1473-1481
47. Bodman-Smith, K. B., Gregory, R. E., Harrison, P. T. and Raynes, J. G. (2004) Fcγ RIIa expression with Fcγ RI results in C-reactive protein and IgG-mediated phagocytosis. J. Leukocyte Biol. 75, 1029-1035
48. Pied, S., Nussler, A., Pontent, M. et al. (1989) C-reactive protein protects against pre-erythrocytic stages of malaria. Infect. Immun. 57, 278-282
49. Holder, A. A., Blackman, M. J., Burghaus, P. A. et al. (1992) A malaria merozoite surface protein (MSP1): structure, processing and function. Mem. Inst. Oswaldo Cruz 87, 37-42
50. Florens, I., Washburn, M. P., Raine, J. D. et al. (2002) A proteomic view of the Plasmodium falciparum life cycle. Nature (London) 419, 520-526
51. 19 are a major component of the invasion-inhibitory response in individuals immune to malaria. J. Exp. Med. 193, 1403-1412
52. Pleass, R. J. and Holder, A. A. (2005) Antibody based therapies for malaria. Nat. Rev. Microbiol. 3, 893-899
53. Pasquier, B., Launay, P., Kanamaru, Y. et al. (2005) Identification of Fcα RI as an inhibitory receptor that controls inflammation: dual role of FcRγ ITAM. Immunity 22, 31-42
54. Wolf, H. M., Hauber, I., Gulle, H. et al. (1996) Anti-inflammatory properties of human serum IgA: induction of IL-1 receptor antagonist and Fcα R (CD89)-mediated down-regulation of tumour necrosis factor-α (TNF-α) and IL-6 in human monocytes. Clin. Exp. Immunol. 105, 537-543
55. Miller, L. H., Good, M. F. and Millon, G. (1994) Malaria pathogenesis. Science 264, 1878-1883
56. Biswas, S., Saxena, Q. B., Roy, A. and Kubilan, L. (1995) Naturally occuring Plasmodium specific IgA antibodies in humans from a malaria endemic area. J. Biosci. 20, 453-460
57. Kassim, O. O., Ako-Anai, K. A., Torimiro, S. E., Hollowell, G. P., Okoye, V. C. and Martin, S. K. (2000) Inhibitory factors in breastmilk, maternal and infant sera against in vitro growth of Plasmodium falciparum malaria parasite. J. Trop. Pediatr. 46, 92-96
58. Otten, M. A., Rudolph, E., Dechant, M. et al. (2005) Immature neutrophils mediate tumor cell killing via IgA but not IgG Fc receptors. J. Immunol. 174, 5472-5480
59. Creasey, A. M., Staalsoe, T., Raza, A., Arnot, D. E. and Rowe, J. A. (2003) Nonspecific immunoglobulin M binding and chondroitin sulfate-A binding are linked phenotypes of Plasmodium falciparum isolates implicated in malaria during pregnancy. Infect. Immun. 71, 4767-4771
60. Flick, K., Scholander, C., Chen, Q. et al. (2001) Role of nonimmune IgG bound to PfEMP1 in placental malaria. Science 293, 2098-2100
61. Perlmann, P., Perlmann, H. and Flyg, B. W. (1997) Immunoglobulin E, a pathogenic factor in Plasmodium falciparum malaria. Infect. Immun. 65, 116-121
62. Kumaratilake, L. M., Ferrante, A., Jaeger, T. and Rzepczyk, C. M. (1992) Effects of cytokines, complement, and antibody on the neutrophil respiratory burst and phagocytic response to Plasmodium falciparum merozoites. Infect. Immun. 60, 3731-3738
63. Salmon, D., Vilde, J. L., Andrieu, B., Simonovic, R. and Lebras, J. (1986) Role of immune serum and complement in stimulation of the metabolic burst of human neutrophils by Plasmodium falciparum. Infect. Immun. 51, 801-806
64. Saeland, E. G., Vidarsson, G., Leusen, J. H. et al. (2003) Central role for complement in passive protection by human IgG1 and IgG2 anti-pneumococcal antibodies in mice. J. Immunol. 170, 6158-6164
65. Vukovic, P., Chen, K., Qin Liu, X. et al. (2002) Single-chain antibodies produced by phage display against the C-terminal 19 kDa region of merozoite surface protein-1 of Plasmodium yoelii reduce parasite growth following challenge. Vaccine 20, 2826-2835
66. Guevara Patino, J. A., Holder, A. A., McBride, J. S. and Blackman, M. J. (1997) Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies. J. Exp. Med. 186, 1689-1699
67. van Spriel, A. B., van Ojik, H. H. and van De Winkel, J. G. (2000) Immunotherapeutic perspective for bispecific antibodies. Trends Immunol. 21, 391-397
68. Stockmeyer, B., Elsasser, D., Dechant, M. et al. (2001) Mechanisms of G-CSF or GM-CSF stimulated tumour cell killing by Fc receptor directed bispecific antibodies. J. Immunol. Methods 248, 103-111
69. Saul, A. and Miller, L. H. (2001) A robust neutralization test for Plasmodium falciparum malaria. J. Exp. Med. 193, 51-54
70. Clynes, R. A., Towers, T. L., Presta, L. G. and Ravetch, J. V. (2000) Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets. Nat. Med. 6, 443-446
71. Segal, D. M., Weiner, G. J. and Weiner, L. M. (2001) Introduction: bispecific antibodies. J. Immunol. Methods 248, 1-194
72. Fanger, M. (1995) Bispecific antibodies. Springer-Verlag, Austin, Texas
73. Underhill, D. M. and Ozinsky, A. (2002) Phagocytosis of microbes: complexity in action. Annu. Rev. Immunol. 20, 825-852
74. van Egmond, M., van Garderen, E., van Spriel, A. B. et al. (2000) Fcα RI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity. Nat. Med. 6, 680-685
75. Ho, M., White, N. J., Looareesuwan, S. et al. (1990) Splenic Fc receptor function in host defense and anemia in acute Plasmodium falciparum malaria. J. Infect. Dis. 161, 555-561
76. Traggiai, E., Becker, S. and Subbarao, K. (2004) An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat. Med. 10, 871-875
77. Bradbury, A. R. M. and Marks, J. D. (2004) Antibodies from phage antibody libraries. J. Immunol. Methods 290, 29-49
78. Fernández, L. A. (2004) Prokaryotic expression of antibodies and affibodies. Curr. Opin. Biotech. 15, 364-373
79. Feldhaus, M. J. and Siegel, R. W. (2004) Yeast display of antibody fragments: a discovery and characterization platform. J. Immunol. Methods 290, 69-80
80. Green, L. L. (1999) Antibody engineering via genetic engineering of the mouse: xenomouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies. J. Immunol. Methods. 231, 11-23